Abstract
Quality of life (QoL) research provides patients and health-care providers with vital information about the impact that disease and its treatment has on physical, functional, social and emotional well-being. QoL outcomes are also being recognized as important prognostic variables, which help to predict which patients are most likely to benefit from treatment. Nevertheless, many remain unreasonably sceptical about the scientific rigour and value of the assessment tools that are available. So how can QoL be measured, and how can this be used for the benefit of patients?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fallowfield, L. J. in The Quality of Life: The Missing Measurement in Health Care 234 (Souvenir Press, London, 1990).
Ware, J. E., Snow, K. K., Kosinski, M. & Gandek, B. SF36 Health Survey Manual and Interpretation Guide. (New England Medical Centre, Boston, Massachusetts, 1993).
Aaronson, N. K. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85, 365–376 (1993).
Cella, D. F. et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J. Clin. Oncol. 11, 570–579 (1993).
McQuellon, R. P. et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 19, 357–368 (1997).
Cella, D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin. Hematol. 34 (Suppl. 2), 13–19 (1997).
Streiner, D. L. & Norman, G. R. in Health Measurement Scales 175 (Oxford Univ. Press, New York, 1989).
Bowling, A. Research Methods in Health. Investigating Health and Health Services (Open Univ. Press, Buckingham, UK, 1989).
The ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359, 2131–2139 (2002).
Fallowfield, L. J. et al. Assesment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine subscale for the FACT-B. Breast Cancer Res. Treat. 55, 189–199 (1999).
Coster, S., Poole, K. & Fallowfield, L. J. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res. Treat. 68, 273–282 (2001).
Saunders, C. M. & Fallowfield, L. J. Survey of the attitudes to and use of quality of life measures by breast cancer specialists in the UK. Breast 5, 425–426 (1996).
Fallowfield, L. J. Quality of quality-of-life data. Lancet 348, 421–422 (1996).
Bernhard, J. et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat. Med. 17, 517–532 (1998).
Sanders, C. et al. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 317, 1191–1194 (1998).
Fallowfield, L. J. et al. The effects of breast conservation on the psychological morbidity associated with the diagnosis and treatment of early breast cancer. BMJ 293, 1331–1334 (1986).
Moyer, A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol. 16, 284–298 (1997).
Fallowfield, L. J. et al. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 301, 575–580 (1990).
Meyer, T. J. & Mark, M. M. Effects of psychosocial interventions with adult cancer patient: a meta analysis of randomised experiments. Health Psychol. 14, 101–108 (1995).
Sheard, T. & Maguire, P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br. J. Cancer 80, 1770–1780 (1999).
Fallowfield, L. et al. Positive epoetin alfa effect on quality of life in anemic cancer patients receiving chemotherapy: results from a randomized placebo–controlled trial. Eur. J. Cancer 35, 1461 (1999).
Coates, A. & Gebski, V. On the receiving end. VI. Which dimensions of quality-of-life scores carry prognostic information? Cancer Treat. Rev. 22 (Suppl. A), 63–67 (1996).
Earlam, S. et al. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J. Clin. Oncol. 14, 171–175 (1996).
Maisey, N. R. et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur. J. Cancer 38, 1351–1357 (2002).
Fraser, S. C. A. et al. A daily diary for quality of life measurement in advanced breast cancer trials. Br. J. Cancer 67, 341–346 (1993).
Brady, M. J. et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J. Clin. Oncol. 15, 974–986 (1997).
Coster, S. & Fallowfield, L. The impact of endocrine therapy on patients with breast cancer: a review of the literature. Breast 11, 1–12 (2002).
Klastersky, J. & Paesmans, M. Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results. Lung Cancer 34 (Suppl. 4), S95–S101 (2001).
Feeny, D. et al. Multi-attribute health-status classification systems: Health Utilities Index. Pharmacoeconomics 7, 490–502 (1995).
Rabin, R. & de Charro, F. EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 33, 337–343 (2001).
Carr-Hill, R. Current practice in obtaining the 'Q' in QALYs: a cautionary note. BMJ 303, 699–701 (1991).
Gelber, R. D., Goldhirsch, A. & Cole, B. F. Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group. Cancer Treat. Rev. 19 (Suppl. A), 73–84 (1993).
Griffin, A. M. et al. On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann. Oncol. 7, 189–195 (1996).
Lachaine, J. et al. Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer. Crit. Rev. Oncol. Hematol. 32, 105–112 (1999).
Velikova, G. et al. Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J. Clin. Oncol. 17, 998–1007 (1999).
Fayers, P. M. & Machin, D. in Quality of Life: Assessment, Analysis and Interpretation 404 (John Wiley & Sons, Chichester, UK, 2000).
Author information
Authors and Affiliations
Related links
Related links
DATABASES
Cancer.gov
LocusLink
FURTHER INFORMATION
Rights and permissions
About this article
Cite this article
Fallowfield, L. Quality of life: a new perspective for cancer patients. Nat Rev Cancer 2, 873–879 (2002). https://doi.org/10.1038/nrc930
Issue Date:
DOI: https://doi.org/10.1038/nrc930